“Can a Pilot Succeed?”: Lessons Learned in Engaging Stakeholders for HPV Introduction

In Madagascar, JSI supported the introduction of HPV vaccine in a two-phase pilot. Lora Shimp and Heather Casciato share the key lessons learned from the program for World Immunization Week.

JSI Expands Access to HPV Vaccine Internationally – and Improves Immunization Rates in our own Backyard

HPV affects millions and millions of people. HPV is the most common sexually transmitted infection, and an estimated 20 million people have the active virus at any time, according to WHO. While in the U.S., the HPV vaccine was licensed for girls in 2006, and for boys in 2009, in many other countries, the vaccine is only just being rolled out now. JSI’s Allison Hackbarth and Vanessa Richart describes efforts being made internationally in and in the U.S. to expand access to HPV vaccine.

Women Deliver Day 1: Saying NO to cervical cancer: Promising advances in global HPV vaccination

Even before my dear friend, Cindy deNeve, died young of cervical cancer, I cared deeply about prevention via HPV vaccination. My new granddaughter and Cindy’s two small daughters will avoid cervical cancer because they can afford the expensive vaccine. Not so for millions of young girls in poor and middle income countries.